Introduction
Rotaviruses are one of the leading causes of severe-dehydrating diarrhoea in infants and young children. The number of global deaths due to rotavirus infection in children under the age of five was estimated to be 215 000 in 2013; of these deaths, 56% occurred in Sub-Saharan Africa [1] . Rotaviruses are taxonomically classified within a genus of the Reoviridae family and contain an 11-segment doublestranded RNA (dsRNA) genome. The dsRNA segments encode six structural (VP1-VP4, VP6 and VP7) and six nonstructural (NSP1-NSP6) proteins. The structural viral proteins (VPs) are assembled in three concentric layers enclosing the genomic segments, the viral RNA-dependent RNA polymerase (VP1) and the viral capping enzyme (VP3). The three capsid layers consist of 60 dimers of the inner capsid protein, VP2, 260 trimers of the middle layer protein, VP6, and 780 monomers of the glycosylated VP7 protein. Spike
Materials and methods

Rotavirus strains
Between February 2012 and September 2013, a cross-sectional study was conducted at two sites in Mozambique; Mavalane General Hospital (MGH) in Maputo and Manhiça District Hospital (MDH) in the Manhiça district (Supplementary Material 1). Faecal samples were collected from children under-five-years old that had been admitted and hospitalized with acute diarrhoea (duration no more than 7 days); defined by three or more looser-than-normal stool passages or watery diarrhoea in the 24 hours prior to the hospital visit. A total of 163 rotavirus positive specimens were detected by EIA (Oxoid, UK) and kept for further analysis [14] .
RNA extraction and RT-PCR genotyping
RNA extraction was performed from 10% faecal sample suspensions in distilled water using the QIAamp Viral RNA Kit (Qiagen, USA), following the manufacturer's instructions. Total RNA was eluted in 60 µL AVE buffer. The extracted RNA was amplified in a reverse-transcription polymerase chain reaction (RT-PCR) with AMV reverse transcriptase (Promega, USA) and Taq DNA polymerase (Promega, USA). The reactions targeted the full VP7 encoding gene (sBeg9/End9; 1062 bp) and the partial VP4 encoding gene for amplification (VP8*; Con3/Con2; 876 bp) [15, 16] as described previously.
G genotyping was carried out by semi-nested, typespecific, multiplex PCR as described previously [15, 17] . Amplicon products from the first round RT-PCR were added to a second round multiplex PCR containing primer RVG9, as well as primers aBT1, aCT2, mG3, aDT4, aAT8v, mG9, G10, and G12b, specific for G types 1, 2, 3, 4, 8, 9, 10, and 12, respectively. A similar approach was followed for P genotyping. First round amplification with primers Con2 and Con3 was added to a reaction containing Con3 and primers 1T-1D, 2T-1, 3T-1, 4T-1, 5T-1, mP11 and p4943, which are specific for types P [8] , P [4] , P [6] , P [9] , P [10] , P [11] and P [14] respectively [16, 18] . The amplicon size generated in the genotyping reactions denotes the respective G and P type and was determined by analysis on a 1.5% agarose gel, as specified previously [15] [16] [17] [18] .
Nucleotide sequencing
Nucleotide sequencing of selected VP7 and VP8* encoding genes was performed using the dideoxynucleotide chain termination method (Supplementary Material 2). Specifically, AMV reverse transcriptase (Thermo Scientific) and KAPA HiFi polymerase (Kapa Biosystems) were used in RT-PCR reactions to amplify the VP7 (sBEG/End9) [15] and VP8* (Con3/Con2) [16] encoding genes. PCR amplicons were purified using the NucleoSpin® PCR clean-up and Gel extraction kit (Macherey-Nagel, Germany), according to the manufacturer's instructions. The nucleotide sequences of these amplicons were determined using the same forward and reverse primers used for amplicon generation and the BigDye terminator v.3.1 kit (Applied Biosystems), again according to the manufacturer's instructions. Sequencing products were analysed on an ABI 3130 Genetic Analyzer (Applied Biosystems) and the resulting electropherograms were edited in CLC Bio (Qiagen).
Data analyses
Sequences were analysed using the Nucleotide Basic Local Alignment Search Tool (BLASTn) and genotypes were confirmed with the online database Virus Pathogen Database and Analysis Resource (ViPR) [19] . The nucleotide sequences of the Mozambican RVA strains have been submitted to GenBank with accession numbers KY315699-KY315722 being assigned to the VP8* and KY426071-KY426094 to the VP7 encoding sequences, respectively. Phylogenetic analyses were carried out using MEGA 7.0.14 [20] . A MUSCLE alignment was performed to align the Mozambican sequences with relevant nucleotide sequences obtained from GenBank. Phylogenetic trees were built with the Maximum Likelihood method using 1000 bootstraps. The Tamura 3 correction parameter was determined as the best substitution model [21] for the VP7 encoding sequences and the Hasegawa-Kishino-Yano model [22] for the VP8* encoding sequences. Amino acid sequences were aligned in Clustal Omega and epitopes were identified as described by Aoki and co-workers [23] . Amino acid sequences of the VP7 Mozambican strains were compared to those of the vaccine strains, RotaTeq ® (SC2-9) G2P [5] (VP7: GU565068) and Rotarix ® (A41CB052A) G1P [8] (VP7: JN849114) whereas VP8* Mozambican sequences were compared to RotaTeq ® (WI79-4) G6P [8] (VP4: GU565044) and Rotarix ® (A41CB052A) G1P [8] (VP4: JN849113). B: P Partially typed samples. C: G/P fully typed samples. X refers to strains that were non-typeable for G or P. Gmix, Pmix and mix type represent samples with more than one G or P type
Results
G-and P-genotypes
For fully typed samples (n = 111), 19 different G and P combinations were observed. The most common G/P combinations detected were G2P [4] at a frequency of 42.3% (47/111) and G12P [6] at 28.8% (32/111; Fig. 1C ). Other genotypes detected at lower frequencies included G8P [4] (4.5%; 5/111) and G12P [8] (5.4%; 6/111). Seven samples had mixed G genotypes, three samples had mixed P genotypes and three samples had both mixed G and P genotypes (Fig. 1C) . Comparison of strain distribution by area revealed that G2P [4] Analyses of the temporal distribution of fully typed strains (n = 111) showed that in 2012 G12P [6] was most prevalent (47.8%; 32/67), followed by mixed infections (19.4%; 13/67; Fig. 2A ). In addition, G12 was detected in combination with P[8] (9.0%; 6/67) and G8 in combination with P[4] (7.5%; 5/67). All mixed infections were detected in 2012. In 2013, the predominant strain was G2P [4] (97.7%; 43/44). A low frequency of G2P [8] (2.3%; 1/44) was also detected (Fig. 2A) . In addition, greater strain diversity was observed in 2012, when compared to 2013 ( Fig. 2A) . Analysis of G and P types by age did not indicate any age-specific genotype association (Fig. 2B) . In general, genotypes G2P [4] and G12P [6] were frequently observed in all age groups.
A total of 24 G and 23 P genotypes were sequenced and the sequencing results correlated with the genotyping Table 1 Frequency of G/P genotype combinations detected in Manhiça (rural) and Mavalane (urban) area X refers to strains that were non-typeable for G or P, NT refers to strains not typed for both G and P. Gmix and Pmix represents samples with more than one G or P type detected 1 could not be confirmed as P [6] . Since the G2 genotype was missing for several samples (by genotyping PCR), the primer binding site of the G2 forward genotyping primer (aCT2) was analysed (Supplementary Material 3). Although differences were observed between the last three nucleotides of the aCT2 primer and the G2 sequences of Mozambican strains, most Mozambican G2 strains could be genotyped using the aCT2 primer [6] as P [8] was also investigated by comparing the primer binding regions for the respective genotypes (Supplementary Material 3). Again, it was not clear why the P [6] primer (3T-1) failed to detect the P [6] genotype using the genotyping PCR. Fifteen of the 18 base pairs in the P [8] genotyping primer (1T-1D) did not match the sequence of RVA/Human-wt/MOZ/0042/2012/GXP [6] and it is therefore unclear why the RVA/Human-wt/MOZ/0042/2012/ GXP [6] strain was incorrectly genotyped as P [8] .
Phylogenetic analysis
Nucleotide-based phylogenetic trees were built for the VP8* and VP7 encoding genes ( Fig. 3A and B) . Ten of the 15 Mozambican P [4] strains clustered together with strains from the Philippines and Zimbabwe in lineage III. These Mozambican strains were detected in 2013 in both Manhiça and Mavalane (Supplementary Material 2). Another P [4] strain (RVA/Human-wt/MOZ/0153/2013/G2P [4] ), detected in Manhiça, clustered with strains from India and Brazil in a separate sub-cluster in lineage III. The remaining four P [4] Mozambican strains, detected in 2012 in Mavalane, formed a sub-cluster with Southern African strains and a South African porcine strain, in lineage II. The two Mozambican P [8] strains formed a sub-cluster in lineage III with a Ugandan strain and a Belgium strain. Another Belgium strain (RVA/Human-wt/BEL/BE0058/2008/G12P [8] ) and a strain detected in Chókwè, Mozambique in 2011 (RVA/ Human-wt/MOZ/21196/2011/GXP [8] ), clustered separately from the Mozambican strains described in this study (Fig. 3A, Supplementary Material 1) . The Mozambican P [6] strains (seven strains detected in 2012) clustered in lineage I. RVA/Human-wt/MOZ/0208/2012/G12P [6] and RVA/ Human-wt/MOZ/0286/2012/G12P [6] formed a sub-cluster in lineage I, whereas the remainder of the P [6] strains clustered with a South African strain detected in 2011 (P [6] encoding sequence of mixed infection, RVA/Human-wt/ ZAF/2371WC/2008/G9P [8] [24]), a strain from India and a strain detected in Chókwè, Mozambique (Fig. 3A) .
All eight Mozambican G12 strains were detected in 2012 and clustered in lineage III (Fig. 3B) . Seven of these strains clustered with strains from Chókwè, Mozambique. The remaining G12 strain (RVA/Human-wt/MOZ/0288/2012/ G12P [8] ) clustered with two Chókwè strains and a Belgian strain. The G12 genotype of strain RVA/Human-wt/ MOZ/0288/2012/G12P [8] associated with the P [8] genotype and also clustered with strains in which the G12 genotype was seen to associate with P [8] . The three Mozambican G8P [4] Table 2 ). The two Mozambican P [8] strains had identical amino acid profiles and differed only in two of the 25 amino acids in the VP8* epitopes, when compared to both the vaccines. Similarly, all the Mozambican P [6] strains had identical amino acid profiles, although 15 of the 25 amino acids were different from the vaccines. Fourteen of these variations were different to both vaccines while one (position 135) was identical to Rotarix ® but different from RotaTeq ® . The Mozambican P [4] strains did not have identical amino acid profiles; the three G8P [4] strains differed from 11 of the 12 G2P [4] strains at positions 150, 115, 113 and 89. Furthermore, the remaining G2P [4] strain, RVA/Humanwt/MOZ/0308/2012/G2P [4] , had an amino acid profile similar to that of the G8P [4] strains, except for a change at position 89, where it was identical to the other G2P [4] strains. Another variation in the G2P [4] group is strain RVA/ Human-wt/MOZ/0153/2013/G2P [4] , which had a proline at position 114, identical to the P [8] strains and both vaccines, but different from the other G2P [4] strains.
The two VP7 epitopes identified in the Mozambican strains were compared to Rotarix ® (A41CB052A) G1 and RotaTeq ® (SC2-9) G2 (Table 3) . Ten of the 13 G2 Mozambican strains had identical amino acid profiles. Both RVA/ Human-wt/MOZ/0428/2013/G2P [4] and RVA/Humanwt/MOZ/0439/2013/G2P [4] had a D146N change which deviates from RotaTeq ® (SC2-9) G2. RVA/Human-wt/ MOZ/0308/2012/G2P [4] had a S242N change which is identical to the RotaTeq ® (SC2-9) G2 profile. The three G8 Mozambican strains had identical amino acid profiles and differed in 12 of the 29 amino acids, when compared with both the vaccines ( Table 3 ). The eight Mozambican G12 strains also had identical amino acid profiles apart from one strain, RVA/Human-wt/MOZ/0288/2012/G12P [8] which had a N130D change. The aspartic acid is identical to the Rotarix ® (A41CB052A) G1 strain, whereas the asparagine is identical to the RotaTeq ® (SC2-9) G2 strain. Thirteen of the 29 amino acids were different between the G12 Mozambican strains and the vaccines.
Discussion
The present study reports the genotyping and molecular characterisation of rotavirus strains from southern Mozambique during 2012-2013. Globally, the most common G and P rotavirus strains are G1-4, G9 and G12 as well as P [4] , P [6] and P [8] [25] . In our study, G2P [4] was the prevalent genotype, accounting for 42.3% of strains detected in 2013. This differed from RVA genotypes detected in 2011 in Chókwè, a site situated closely to the area reported in this study. The G2P [4] genotype has been reported worldwide [26] and was also reported to be the predominant type (47.0%) circulating in South African in 2013 [27] . However, it is important to highlight that Mozambique had not yet introduced rotavirus vaccines during the study period while South Africa introduced Rotarix ® into their Expanded Programme on Immunisation in 2009.
The second most frequent genotype was G12P [6] (28.8%). The G12 genotype was also detected at lower frequencies with P [8] and P [4] types. Previously, G12P [8] strains were predominant (57.0%) in Mozambique in 2011 [13] . The African Rotavirus Surveillance Network also reported the detection of G12P [6] and G12P [8] in 2012, but at much lower frequencies of 6.0% and 12.0%, respectively [26] .
We also detected uncommon genotypes such as G8P [4] and G8P [8] , albeit at low rates (4-5.0%). The G8 genotype is known to cause infection in cattle and has been responsible for rotavirus infection in humans, mainly in African countries [28, 29] . Recently it was reported that G8P [6] was the predominant type in São Tome Principe in 2011, being responsible for 71.1% of rotavirus cases [30] . Other genotypes detected in low frequencies were G1P [8] and G9P [8] . Genotype G1P [8] strains were the second most common genotype detected in the Chókwè study [13] . The G9 genotype was not observed at high frequencies in either the current study or the study carried out in Chókwè.
In our study, we observed a difference in distribution of rotavirus strains between the two years. In 2012, G12P [6] was predominant and more rotavirus strain diversity was noted. Genotype G2P [4] was prevalent in 2013 and in less diversity genotypes was observed compared to 2012. Variation in circulating rotavirus genotypes can occur yearly [26] , with the change due to the natural variability of rotavirus strains over time. It has been suggested that rotavirus vaccines may influence the distribution of genotypes [31] . A study carried out in Belgium reported a higher prevalence of G2P [4] in vaccinated rotavirus gastroenteritis patients than in unvaccinated rotavirus gastroenteritis patients [32] . In Mozambique, the prevalence of G2P [4] will require continuous monitoring, especially because of the introduction of rotavirus vaccines in 2015.
Geographical differences in genotype distribution within the same country or region can occur [25] . We also observed differences in the geographical distribution of genotypes. In Mavalane, an urban area, G12P [6] (28.6%) was the most prevalent, while in contrast to Manhiça, a rural area, G2P [4] (39.4%) was predominant.
During the study 10.8% (17/157) of the samples were untypeable for G or P, which is comparable to the rate of untypeable samples previously reported from Sub-Saharan countries (8.6-14.6%) [26] . It was noted that in Manhiça a higher number of untypeable strains (16.7%) was observed, when compared to Mavalane, the urban area (6.6%). [8] detected in South Africa contained multiple genotypes and the sequence in this analysis is based on the P [6] genotype [23] . B: Phylogenetic tree of VP7 encoding sequences. The tree is based on the Tamura 3-parameter gb|KJ752997.1| RVA/Human-wt/ZWE/MRC-DPRU1132/XXXX/G2P [4] gb|KY315719| RVA/Human-wt/MOZ/0439/2013/G2P [4] gb|KY315701| RVA/Human-wt/MOZ/0113/2013/G2P [4] gb|KY315702| RVA/Human-wt/MOZ/0117/2013/G2P [4] gb|KY315704| RVA/Human-wt/MOZ/0146/2013/G2P [4] gb|KY315720| RVA/Human-wt/MOZ/0440/2013/G2P [4] gb|KY315721| RVA/Human-wt/MOZ/0441/2013/G2P [4] gb|KY315722| RVA/Human-wt/MOZ/0448/2013/G2P [4] gb|KY315703| RVA/Human-wt/MOZ/0131/2013/G2P [4] gb|KY315705| RVA/Human-wt/MOZ/0151/2013/G2P [4] gb|KY315718| RVA/Human-wt/MOZ/0428/2013/G2P [4] gb|KP007149| RVA/Human-wt/PHI/TGO12-003/2012/G2P [4] gb|JN849123.1| RVA/Human-wt/BEL/BE1058/2008/G2P [4] gb|HQ657174.1| RVA/Human-wt/ZAF/3203WC/2009/G2P [4] gb|KC443225| RVA/Human-wt/AUS/CK20037/2008/G2P [4] gb|JN849129.1| RVA/Human-wt/BEL/BE1248/2009/G2P [4] gb|KP222876.1| RVA/Human-wt/MOZ/21197/2011/GXP [4] gb|JN849155.1| RVA/Human-wt/BEL/BE1141/2009/G2P [4] gb|KJ752408.1| RVA/Human-wt/ZAF/MRC-DPRU81/2007/G2P [4] gb|KF636325.1| RVA/Human-wt/ZAF/MRC-DPRU1061/2009/G2P [4] gb|JN849143.1| RVA/Human-wt/BEL/BE1251/2009/G2P [4] gb|KU360902.1| RVA/Human-wt/BRA/QUI-36-F1/2008/G2P [4] gb|KY315706| RVA/Human-wt/MOZ/0153/2013/G2P [4] gb|JX307596.1| RVA/Human-wt/IND/mcs65/2011/G8P [4] gb|HQ650119.1| RVA/Human-tc/USA/DS-1/1976/G2P [4] gb|KF636248.1| RVA/Human-wt/KEN/MRC-DPRU1606/2009/G8P [4] gb|KJ752461.1| RVA/Human-wt/ZWE/MRC-DPRU3347/2010/G8P [4] gb|KF636314.1| RVA/Human-wt/ZMB/MRC-DPRU3463/2009/G8P [4] gb|KJ752375.1| RVA/Pig-wt/ZAF/MRC-DPRU1533/2007/G2P [4] gb|KJ752208.1| RVA/Human-wt/ZAF/MRC-DPRU82/2012/G2P [4] gb|KY315716| RVA/Human-wt/MOZ/0308/2012/G2P [4] gb|KY315717| RVA/Human-wt/MOZ/0310/2012/G8P [4] gb|KY315714| RVA/Human-wt/MOZ/0297/2012/G8P [4] gb|KY315710| RVA/Human-wt/MOZ/0285/2012/G8P [4] gb|JN849113.1| RVA/Vaccine/USA/Rotarix-A41CB052A/1988/G1P1A [8] gb|JX406750.2| Rotavirus A strain Human-tc/USA/Wa/1974/G1P [8] gb|EF672619.1| RVA/Human-tc/USA/WI61/1983/G9P1A [8] gb|GU565044.1| RVA/Vaccine/USA/RotaTeq-WI79-4/1992/G6P1A [8] gb|GU226776.1| RVA/Human-wt/RUS/NN544/2009G4P [8] gb|GU226775.1| RVA/Human-wt/RUS/NN520/2009/G4P [8] gb|KP222875.1| RVA/Human-wt/MOZ/21196/2011/GXP [8] gb|JN849115.1|RVA/Human-wt/BEL/BE0085/2008/G12P [8] gb|JN849117.1|RVA/Human-wt/BEL/BE0258/2008/G12P [8] gb|KJ753730.1| RVA/Human-wt/UGA/MRC-DPRU4620/2011/G12P [8] gb|KY315712| RVA/Human-wt/MOZ/0288/2012/G12P [8] gb|KY315700| RVA/Human-wt/MOZ/0060/2012/GXP [8] gb|KJ659445.1| RVA/Pig-tc/USA/LS00008/1975/G4P [6] gb|M33516.1| RVC/Pig-tc/USA/Gottfried/1983/G4P [6] gb|KP222867.1| RVA/Human-wt/MOZ/21178/2011/G2P [6] gb|JF460815.1| RVA/Human-wt/USA/06-242/2006/G2P [6] gb|JN013996.1| RVA/Human-wt/ZAF/2371WC/2008/G9P[8]* gb|JQ255030.1| RVA/Human-wt/BFA/259-BF/2010/G1P [6] gb|KY315711| RVA/Human-wt/MOZ/0286/2012/G12P [6] gb|KY315707| RVA/Human-wt/MOZ/0208/2012/G12P [6] gb|JX411975.1| RVA/Human/India/UK-HLD/H21/2011/GXP [6] gb|KJ752817.1| RVA/Human-wt/ZAF/MRC-DPRU4090/2011/G12P [6] gb|KP222866.1| RVA/Human-wt/MOZ/21168/2011/G12P [6] gb|KY315715| RVA/Human-wt/MOZ/0304/2012/G12P [6] gb|KY315713| RVA/Human-wt/MOZ/0289/2012/GXP [6] gb|KY315709| RVA/Human-wt/MOZ/0278/2012/G12P [6] gb|KY315708| RVA/Human-wt/MOZ/0211/2012/G12P [6] gb|KY315699| RVA/Human-wt/MOZ/0042/2012/GXP [6] gb|AB009632.2| RVA/Pidgeon-tc/JPN/PO-13/1983/G18P [17] [6] gb|KY426079| RVA/Human-wt/MOZ/0277/2012/G12P [6] gb|KP222828.1| RVA/Human-wt/MOZ/21153/2011/G12P [8] gb|KP222837.1| RVA/Human-wt/MOZ/21164/2011/G12P [6] gb|KP222840.1| RVA/Human-wt/MOZ/21168/2011/G12P [6] gb|KY426082| RVA/Human-wt/MOZ/0211/2012/G12P [6] gb|KY426083| RVA/Human-wt/MOZ/0286/2012/G12P [6] gb|KY426081| RVA/Human-wt/MOZ/0304/2012/G12P [6] gb|KY426078| RVA/Human-wt/MOZ/0208/2012/G12P [6] gb|KY426071| RVA/Human-wt/MOZ/0050/2012/G12P [X] gb|KP222839.1| RVA/Human-wt/MOZ/21167/2011/G12P [6] gb|KJ752819.1| RVA/Human-wt/ZAF/MRC-DPRU4090/2011/G12P [6] gb|KP752806.1| RVA/Human-wt/MUS/MRC-DPRU308/2012/G2G12P [X] gb|JN849116.1|RVA/Human-wt/BEL/BE0085/2008/G12P [8] gb|JN849118.1|RVA/Human-wt/BEL/BE0258/2008/G12P [8] gb|KY426084| RVA/Human-wt/MOZ/0288/2012/G12P [8] gb|KP222827.1| RVA/Human-wt/MOZ/21150/2011/G12P [8] gb|KP222838.1|RVA/Human-wt/MOZ/21165/2011/G12P [8] gb|AB125852| RVA/Human-wt/JPN/CP727/XXXX/G12P [9] gb|EU496259.1| RVA/Human-wt/KOR/Kor588/2002/G12P [9] gb|KJ412580.1| RVA/Human-wt/PRY/1471SR/2006/G12P [9] gb|AY855065.1| RVA/Human/BRZ/HC91/XXXXG12P [X] gb|AB071404| RVA/Human-tc/THA/T152/1998/G12P [9] gb|EU496254.1| RVA/Human-wt/ARG/Arg721/1999/G12P [9] gb|JX307592.1| RVA/Human-wt/IND/mcs65/2011/G8P [4] gb|GQ398012.1| RVA/Human-wt/AUS/WAG8.1/2002/G8P [14] gb|KY426086| RVA/Human-wt/MOZ/0297/2012/G8P [4] gb|KY426087| RVA/Human-wt/MOZ/0310/2012/G8P [4] gb|KY426085| RVA/Human-wt/MOZ/0285/2012/G8P [4] gb|HRU73955| RVA/Human-wt/AUS/95A/XXXX/G2P [X] gb|GU565068.1| RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P7 [5] gb|JF304931.1| RVA/Human-wt/KEN/AK26/1982/G2P [4] gb|HQ650124.1| RVA/Human-tc/USA/DS-1/1976/G2P [4] gb|AY261338.1| RVA/Human-wt/ZAF/514GR/87/1987/G2P [4] gb|JN849130.1| RVA/Human-wt/BEL/BE1248/2009/G2P [4] gb|KY426088| RVA/Human-wt/MOZ/0308/2012/G2P [4] gb|KJ752210.1| RVA/Human-wt/ZAF/MRC-DPRU82/2012/G2P [4] gb|KF636327.1| RVA/Human-wt/ZAF/MRC-DPRU1061/2009/G2P [4] gb|KJ752410.1| RVA/Human-wt/ZAF/MRC-DPRU81/2007/G2P [4] gb|KP222843.1| RVA/Human-wt/MOZ/21178/2011/G2P [6] gb|JN849156.1| RVA/Human-wt/BEL/BE1141/2009/G2P [4] gb|KM288569| RVA/Human-wt/RUS/NN/2578/2011/G2P [4] gb|KM288568| RVA/Human-wt/RUS/NN/2406/2011/G2P [4] gb|JN849124.1| RVA/Human-wt/BEL/BE1058/2008/G2P [4] gb|KJ638611.1| RVA/Human-wt/BRA/RJ12398/2006/G2P [4] gb|KP752805.1| RVA/Human-wt/MUS/MRC-DPRU308/2012/G2G12P [X] gb|KP752665.1| RVA/Human-wt/MUS/MRC-DPRU295/2012/G2P [4] gb|KY426089| RVA/Human-wt/MOZ/0412/2013/G2P [X] gb|KY426077| RVA/Human-wt/MOZ/0153/2013/G2P [4] gb|KY426094| RVA/Human-wt/MOZ/0448/2013/G2P [4] gb|KY426092| RVA/Human-wt/MOZ/0440/2013/G2P [4] gb|KY426076| RVA/Human-wt/MOZ/0151/2013/G2P [4] gb|KY426091| RVA/Human-wt/MOZ/0439/2013/G2P [4] gb|KY426090| RVA/Human-wt/MOZ/0428/2013/G2P [4] gb|KY426073| RVA/Human-wt/MOZ/0117/2013/G2P [4] gb|KY426075| RVA/Human-wt/MOZ/0146/2013/G2P [4] gb|KY426093| RVA/Human-wt/MOZ/0441/2013/G2P [4] gb|KY426072| RVA/Human-wt/MOZ/0113/2013/G2P [4] gb|KY426074| RVA/Human-wt/MOZ/0131/2013/G2P [4] Black background: Mozambican strains are different from both RotaTeq ® (SC2-9) G2P [5] and Rotarix ® (A41CB052A) G1P [8] No correlation between age group and genotype was observed in this study, although it has been reported previously [33] . In a study investigating the prevalence and genotype distribution of RVA among children with acute gastroenteritis in Kunming, China, genotype G2P [4] was observed in patients between 12 and 48 months of age [34] . However, here we observed the occurrence of G2P [4] below 12 months of age, and even below 5 months (Fig. 2B) .
Analyses of primer binding sites did not shed light on the discrepancies between PCR-genotyping results and nucleotide sequencing. In our study, mixed genotypes were observed in 11.7% (13/111) of the samples typed for G and P. This is similar to the 12-14% mixed genotypes reported by the African Rotavirus Surveillance Network [26] .
The phylogenetic analyses provided some evidence on the widespread circulation of rotavirus strains in Mozambique, with similar strains detected in Manhiça, Mavalane and Chókwè (Supplementary Material 1) . The Chókwè G12 and P [6] strains phylogenetically clustered with strains detected in the current study indicating that these strains circulated in southern Mozambique from 2011 to 2013 (Fig. 3A, B) . Interestingly, no G8 strains were identified in the Chókwè study during 2011 [13] .
The genotypes of the Mozambican strains clustered mostly with those of strains detected in other African countries, specifically South Africa (G12, G2, P [6] ), Uganda (P [8] ), Zambia (G12), and Zimbabwe (P [4] ; Fig. 3A, B) . South Africa, Zambia and Zimbabwe share borders with Mozambique and the circulation of similar rotavirus strains between these countries is not unusual. The South African strains (RVA/Human-wt/ZAF/MRC-DPRU4090/2011/ G12P [6] and RVA/Human-wt/ZAF/MRC-DPRU82/2012/ G2P [4] ) are closely related to the strains from southern Mozambique (Fig. 3A, B) . Strains from other countries, which also grouped with Mozambican strains, were from India (P [4] , P [6] ), Mauritius (G12) and the Philippines (P [4] ; Fig. 3A, B) .
One exception, where the Mozambican strains did not cluster close together, is RVA/Human-wt/MOZ/0153/2013/ G2P [4] . This strain clustered with an Indian (RVA/Humanwt/IND/mcs65/2011/G8P [4] ) and a Brazilian (RVA/Humanwt/BRA/QUI-36-F1/2008/G2P [4] ) strain in the P [4] lineage III. However, RVA/Human-wt/MOZ/0153/2013/G2P [4] grouped with the other Mozambican strains in lineage G2 IV. The sequencing of the VP8* encoding gene suggests that RVA/Human-wt/MOZ/0153/2013/G2P [4] is a reassortant strain. Interestingly, analysis of the VP8* epitope showed that the Mozambican P [4] strains in lineage III had identical amino acid profiles apart from a proline (instead of a glycine) in strain RVA/Human-wt/MOZ/0153/2013/G2P [4] at position 114. The Indian and Brazilian strains that grouped with this Mozambican strain also have a proline at position 114.
